搜索临床试验以：Camrelizumab (SHR-1210)、培美曲塞和卡铂
总计765个结果
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Guangdong Association of Clinical Trials尚未招聘
-
Hospital of Stomatology, Wuhan UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
Hospital of Stomatology, Wuhan UniversityJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Peking Union Medical College Hospital招聘中
-
Shanghai Chest Hospital尚未招聘
-
Fudan UniversityShanghai Shen Kang Hospital Development Center主动，不招人
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Shengdi Pharmaceutical Co., Ltd尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.完全的局部晚期或转移性和不可切除的 HCC美国, 西班牙, 中国, 台湾, 比利时, 大韩民国, 意大利, 香港, 俄罗斯联邦, 乌克兰, 火鸡, 波兰, 德国
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Jiangsu HengRui Medicine Co., Ltd.完全的肺部疾病 | 按部位分类的肿瘤 | 癌，非小细胞肺癌 | 肺肿瘤 | 呼吸道肿瘤 | 胸部肿瘤 | 癌，支气管癌 | 呼吸道疾病 | 肿瘤，支气管中国
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Huazhong University of Science and Technology尚未招聘
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Jiangxi Provincial Cancer Hospital; Shenzhen People's Hospital 和其他合作者招聘中
-
Jiangsu HengRui Medicine Co., Ltd.主动，不招人
-
Peking Union Medical College Hospital未知